Abortion :: Abortion linked with partner violence
Partner violence is the strongest predictive factor of whether young women with unwanted pregnancies will choose to terminate, a study by La Trobe University has found.
Healthcare
Flu :: New web tool preparing GPs for flu outbreak
A new online simulation to help GPs prepare their practice for a pandemic influenza outbreak has been launched today by a research team based at The Australian National University.
Breastfeeding :: HIV study prompts call for revision of breastfeeding guidelines
A study by scientists at the Africa Centre for Health and Population Studies, South Africa, has shown that exclusive breastfeeding can significantly reduce the risk of HIV transmission from mother to child in infants aged under six months when compared to those also given solid foods or replacement feed (i.e. formula milk).
Osteoporosis :: Call for greater use of comparative effectiveness studies to help advance disease management
The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
Irritable Bowel Syndrome :: Novartis suspends US marketing and sales of Zelnorm
Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation.
Breast Cancer :: GSK seeks approval for lapatinib for breast cancer patients in Japan
GlaxoSmithKline K.K. (Head Office: Shibuya-ku, Tokyo, President: Marc Dunoyer, hereinafter referred to as GSK) announced the submission of a New Drug Application (NDA) to the Japanese authorities for approval to market lapatinib, its new cancer drug on 30 March.
NHS :: Minister gives support to NHS foundation trusts
UK Health Minister Andy Burnham declared his support for nine NHS Trusts applying for foundation status and welcomed the authorisation of three more Foundation Trusts by the independent regulator, Monitor.
Clotting Disorder :: FDA approves Ceprotin biologic to treat rare clotting disorder
The U.S. Food and Drug Administration (FDA) licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.
NHS :: NHS Confederation comment on Healthcare Commission’s diagnostic waiting report
Nigel Edwards, director of policy at the NHS Confederation which represents over 90 per cent of NHS organisations, said:
Mental Health :: Still some way to go in tackling racism in mental health care
Mental health services in England and Wales have been accused of being institutionally racist. In this week?s BMJ, two senior doctors say that, although services are pioneers in moving towards equity, they have some way to go before they meet the challenges of a multi-cultural society.